The screening assay platform at Simbiosys leverages our extensive range of biology and biochemistry capabilities to offer a broad selection of therapeutic target-based cell-based and biochemical assays. HTS formats for most assays are available.

Simbiosys offers primary and secondary screening assays against a portfolio of clinically validated and emerging therapeutic targets for diabetes and obesity. We also offer screening solutions using validated and emerging cell model systems for targeted therapies against cancer.

Simbiosys is also developing specialized cell-based in-vitro ADME assays starting with the Blood Brain Barrier permeability assay.